Lupin Gets Tentative Approval from US FDA for Empagliflozin, Linagliptin and Metformin Hydrochloride
Lupin has secured tentative approval from the United States Food and Drug Administration (US FDA)for its Abbreviated New Drug Application for Empagliflozin, Linagliptin and Metformin Hydrochloride Extended-Release (ER) Tablets.
Empagliflozin | 10/07/2024 | By Aishwarya | 263
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy